Cover image of the article: Rabies Neutralizing Antibody Level in Immunosuppressed Patients After Receive of Rabies Post-Exposure Prophylaxis

Image Credit:Arch Clin Infect Dis

Rabies Neutralizing Antibody Level in Immunosuppressed Patients After Receive of Rabies Post-Exposure Prophylaxis

Authors

Vida Fallahian,*, Ali Eslamifar3, Mohammad Amin Fayaz4, Parisa Mashayekhi2, Peyvand Biglari1
3Department of Clinical Research, Pasteur Institute of Iran, Tehran, IR Iran
4Student of Veterinary Faculty of Tehran University, Tehran, IR Iran
2Prevention and Treatment of Rabies Center, Department of Vaccination, Pasteur Institute of Iran, Tehran, IR Iran
1WHO Collaborating Center for Reference and Research on Rabies, Pasteur Institute of Iran, Tehran, IR Iran
*Corresponding Author: Prevention and Treatment of Rabies Center, Department of Vaccination, Pasteur Institute of Iran, Tehran, IR Iran, vida.1333@yahoo.com. Tel: +98-2166953311-20. Fax: +98-2166496864. Email: vida.1333@yahoo.com

Archives of Clinical Infectious Diseases:Vol. 6, issue 3; 124-7
Published online:Jul 31, 2011
Article type:Brief Report
How to Cite:Fallahian V, Eslamifar A, Fayaz MA, Mashayekhi P, Biglari P. Rabies Neutralizing Antibody Level in Immunosuppressed Patients After Receive of Rabies Post-Exposure Prophylaxis. Arch Clin Infect Dis. 2011;6(3):. doi:

Abstract

Introduction:

Rabies is a fatal disease and has a threatening risk for the public health. Immunosuppression is related to a wide variety of diseases. It is recommended that immunosuppressed patients receive the full post-exposure vaccination, concerning that the immune response may be inadequate. The aim of this study is to determine the level of rabies neutralizing antibody in immunosuppressed patients after receiving rabies post-exposure prophylaxis. Consequently we assess the efficiency of antibody level in immunosuppressed patients admitted at Pasteur Institute of Iran.

The study was performed at Pasteur Institute of Iran. Data related to immunosuppressed patients, doses of anti-rabies vaccine and serum, and level of rabies neutralizing antibody titer collected from the patients admitted to the Prevention and Treatment of Rabies Center, Department of Vaccination at Pasteur Institute of Iran, during 2008 to 2010. Subjects who received chemotherapy, immunosuppressive drugs, and chronic renal failure were included in this study.

Results:

Twenty two cases were evaluated. The Immunosuppressed state was related to cancer (in 8 cases), 4 cases of hematologic disorders, 6 cases of autoimmune disease, and 4 cases of chronic renal failure or kidney transplant. Mean age of 46.45 21.5 year. All cases received HRIG serum (human rabies immunoglobulin) plus PVRV (Purified Vero cell rabies vaccine). The level of rabies neutralizing antibody was checked two weeks after the last dose of vaccine. Mean level of rabies neutralizing antibody was 12.07 6.72 IU/ml. All cases achieved minimum protective level of antibody which is ? 0.5 IU/ml. The amount of the antibody level had no relation to age or kind of immunosuppressive disease of patients.

Conclusion:

It is recommended that Rabies-exposed immunosuppressed patients receive rabies post exposure prophylaxes. We have to be cautious about the cases who have not achieved the appropriate level of rabies antibody.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

24
Mar
2020

Acute and critical care for rabies bitten patients and the different outcomes in a Family: A Post Exposure Prophylaxis (PEP) Failure report

Sara Nouri Basirat,
Rouzbeh Bashar,
Dr Behzad Pourhossain,
Nasim Niknam,
Mojtaba Sanji Rafsanjani,
Mohammad Reza Shirzadi
,et al.

Nouri Basirat S, Bashar R, Pourhossain DB, Niknam N, Sanji Rafsanjani M, et al. Acute and critical care for rabies bitten patients and the different outcomes in a Family: A Post Exposure Prophylaxis (PEP) Failure report. J Cell Mol Anesth. 2019;4(4):e149595. doi: https://doi.org/10.22037/jcma.v4i4.29172

28
Mar
2016
Delay in Post-Exposure Prophylaxis and Associated Factors Among People Bitten by Animals in the Northeast of Iran, 2015

Delay in Post-Exposure Prophylaxis and Associated Factors Among People Bitten by Animals in the Northeast of Iran, 2015

Salman Khazaei,
Shahab Rezaeian,
Hamid Salehiniya,
Razieh Rezaei,
Javad Torkaman Nejad Sabzavari,
Mokhtar Soheilyzad

Khazaei S, Rezaeian S, Salehiniya H, Rezaei R, Torkaman Nejad Sabzavari J, et al. Delay in Post-Exposure Prophylaxis and Associated Factors Among People Bitten by Animals in the Northeast of Iran, 2015. Arch Clin Infect Dis. 2016;11(2):e33904. doi: https://doi.org/10.5812/archcid.33904

30
Jun
2014
Rabies Vaccination in a Pediatric Patient with Acute Myeloid Leukemia during the Course of Chemotherapy: a Case report

Rabies Vaccination in a Pediatric Patient with Acute Myeloid Leukemia during the Course of Chemotherapy: a Case report

viroj wiwanitkit

wiwanitkit V. Rabies Vaccination in a Pediatric Patient with Acute Myeloid Leukemia during the Course of Chemotherapy: a Case report. Int J Cancer Manag. 2014;7(2):e80532. doi:

30
Oct
2009
Animal Bites and Rabies in Northern Iran, 2001–2005

Animal Bites and Rabies in Northern Iran, 2001–2005

Narges Najafi,
roya ghasemian

Najafi N, ghasemian R. Animal Bites and Rabies in Northern Iran, 2001–2005. Arch Clin Infect Dis. 2009;4(4):e93403. doi:

13
Jul
2014
Severe Abdominal Pain as the First Manifestation of Rabies

Severe Abdominal Pain as the First Manifestation of Rabies

Jamshid Ayatollahi,
Mohammad Reza Sharifi,
Seyed Hossein Shahcheraghi

Ayatollahi J, Sharifi MR, Shahcheraghi SH. Severe Abdominal Pain as the First Manifestation of Rabies. Jundishapur J Microbiol. 2014;7(8):e11671. doi: https://doi.org/10.5812/jjm.11671

More by these authors

Vida FallahianPubMedScholar
Ali EslamifarPubMedScholar
Mohammad Amin FayazPubMedScholar
Parisa MashayekhiPubMedScholar
Peyvand BiglariPubMedScholar
Share
Cited by
Metrics